Skip to main content

Table 3 Plasma hTERT mRNA level in NPC patients at stages I and II before and after radiotherapy

From: Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance

Group hTERT mRNA (2-Ct) (X ± SD) P value
Before radiotherapy 5.60 ± 2.33 0.014
After radiotherapy 3.43 ± 1.42